Börskollen - Aktier, fonder och ekonominyheter
Börskollen
•Kom igång: Börja spara i fonder 2026? Se vår kompletta guide för nybörjare

Pressmeddelanden från Nightingale Health

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts
05 mar 08:00
Nightingale Health
Nightingale Health's half-year report: Delivering clinical value for healthcare and moving toward 50% revenue growth, supported by a strong sales pipeline09 feb 20:30
Nightingale Health
Inside information: Nightingale Health achieves major milestone in the United States: New York laboratory now holds a clinical laboratory permit from New York State18 dec 2025 14:00
Nightingale Health
Uusi hyvinvointialue mukaan – Pohjois-Karjala ottaa käyttöön sairastumisriskien tunnistamisen osana julkista terveydenhuoltoa17 dec 2025 08:30
Nightingale Health
Merkittävä tutkimus: Nightingale Healthin verianalyysi auttaa estämään 44 % enemmän sydäninfarkteja ja aivohalvauksia verrattuna nykyiseen terveydenhuollon käytäntöön12 dec 2025 13:55
Nightingale Health
Nightingale Health Oyj uudistaa johtoryhmänsä kokoonpanoa tukemaan terveydenhuollon liiketoiminnan kasvuvaihetta08 dec 2025 09:35
Nightingale Health
Change in Nightingale Health Plc’s Management Team26 nov 2025 10:00
Nightingale Health
Terveystalo and Nightingale Health deepen strategic partnership – preventive healthcare available to all Terveystalo customers in Finland20 nov 2025 09:00
Nightingale Health
Nightingale Health enables access to world’s largest metabolomics dataset through UK Biobank collaboration06 nov 2025 16:10
Nightingale Health
Nightingale Health Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset05 nov 2025 11:50
Nightingale Health
Nightingale Health partners with Alamar Biosciences to expand its unique multiomics offering with ultra-sensitive proteomics for brain health02 okt 2025 14:30
Nightingale Health
Kutsu Nightingale Health Oyj:n varsinaiseen yhtiökokoukseen02 okt 2025 08:00
Nightingale Health
Nightingale Healthin vuosikertomus tilikaudelta 2024–2025 on julkaistu25 sep 2025 11:10
Nightingale Health
Breakthrough in cardiovascular disease risk assessment – Nightingale Health to offer Lp(a) risk detection as part of its routine health check18 sep 2025 08:00
Nightingale Health
Nightingale Health Plc Financial Statements Release 1 July 2024 – 30 June 202516 sep 2025 09:25
Nightingale Health
Inside information: Nightingale Health selected as multiomics provider for EUR 2.4 million research project08 sep 2025 15:10
Nightingale Health
Nightingale Health Oyj:n EMP-osakkeiden muunto B-sarjan osakkeiksi07 jul 2025 07:00
Nightingale Health
Nightingale Health valittu palveluntarjoajaksi merkittävään italialaiseen väestötutkimukseen02 jul 2025 11:55
Nightingale Health
Sisäpiiritieto, tulosvaroitus: Nightingale Healthin liikevaihto kasvaa, ja oikaistu käyttökate heikkenee edelliseen tilikauteen verrattuna30 jun 2025 16:15
Nightingale Health
Nightingale Healthin laboratorio Yhdysvalloissa nyt avattu16 jun 2025 08:35
Nightingale Health
Maailmanlaajuisesti ainutlaatuinen ennaltaehkäisevän terveydenhuollon hanke käynnistyy Suomessa: julkinen terveydenhuolto ottaa käyttöön Nightingale Healthin sairastumisriskejä tunnistavan teknologian13 jun 2025 10:50
Nightingale Health
Nightingale Health vahvistaa kaupallista toimintaansa nimittämällä uuden johtajan EMEA-alueelle12 jun 2025 15:15
Nightingale Health
Nightingale Healthin johtoryhmän jäsenet Minja Salmio ja Satu Saksman saivat tunnustusta erinomaisesta johtajuudesta09 jun 2025 15:15
Nightingale Health
Nightingale Healthin hallitus on päättänyt uudesta optio-ohjelmasta02 maj 2025 15:45
Nightingale Health
Muutoksia Nightingale Health Oyj:n johtoryhmässä23 apr 2025 17:15
Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares10 apr 2025 08:30
Nightingale Health
Nightingale Health’s laboratory implementation in the United States progresses as planned – opens first to medical research customers in Summer 202521 mar 2025 12:00
Nightingale Health
Trading in Nightingale Health’s B shares and ADRs begins on 21 March 2025 on the OTCQX International Market in the US18 mar 2025 10:30
Nightingale Health
Nightingale Health Plc’s listing application has been approved and trading in its Series B shares on the Main Market of Nasdaq Helsinki will commence on 19 March 202517 mar 2025 15:15
Nightingale Health
The Finnish Financial Supervisory Authority has approved Nightingale Health Plc’s Finnish prospectus17 mar 2025 12:55
Nightingale Health
Nightingale Health establishes ADR program in the US – trading in Company’s B shares and ADRs begins on 19 March 2025, at the earliest, and 24 March 2025, at the latest, on the OTCQX Market in the US12 mar 2025 13:30
Nightingale Health
Nightingale Health Plc applies for its series B shares to be listed on the Main Market of Nasdaq Helsinki06 mar 2025 08:00
Nightingale Health
Nightingale Health’s half-year report: International expansion continues in Southeast Asia and the United States28 feb 2025 11:35
Nightingale Health
Nightingale Health to publish half-year report for July – December 2024 on 6 March 202527 feb 2025 13:15
Nightingale Health
Nightingale Health announces the development of innovative LLM based tool to empower anyone to take informed decisions to lower disease risks07 feb 2025 13:15
Nightingale Health
Nightingale Health announces its updated regulatory plan in the United States27 jan 2025 08:00
Nightingale Health
Nightingale Health and Enigma Genomics enter into collaboration to sell the Nightingale Remote Health Check in the MENA region23 jan 2025 10:00
Nightingale Health
Nightingale Health announces the performance metrics of its latest generation disease risk assessments to be rolled out in Singapore and the United States23 dec 2024 13:00
Nightingale Health
Conversion of Nightingale Health Plc’s EMP shares to Series B shares20 dec 2024 16:35
Nightingale Health
Nightingale Health Plc – Managers’ Transactions – Olli Karhi18 dec 2024 20:35
Nightingale Health
Nightingale Health Plc appoints Lago Kapital as liquidity provider13 dec 2024 14:50
Nightingale Health
Nightingale Health Plc: Subscription of Series B shares with option rights04 dec 2024 09:00
Nightingale Health
Study published in Nature Communications: Nightingale Health outperforms genetic testing in chronic disease risk detection and makes the promise of preventative health a reality29 nov 2024 10:30
Nightingale Health
Nightingale Health announces opening of its Singapore laboratory27 nov 2024 13:20
Nightingale Health
Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S.14 nov 2024 08:15
Nightingale Health
Nightingale Health Asia achieves ISO 13485:2016 certification and completes regulatory readiness to launch its blood testing service in Singapore08 nov 2024 16:00
Nightingale Health
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc06 nov 2024 08:45
Nightingale Health
Renowned international expert in medicine Dr. Charles Alessi joins Nightingale Health UK as Chief Medical Officer30 okt 2024 08:35
Nightingale Health
Nightingale Health and Boston Heart Diagnostics have successfully completed their pilot and move to the production phase expanding the use of Nightingale’s Health Check in the US10 okt 2024 12:00
Nightingale Health
Notice to the Annual General Meeting of Nightingale Health Plc10 okt 2024 08:00
Nightingale Health
Nightingale Health’s Annual Report for financial year 2023–2024 has been published09 okt 2024 13:30
Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares20 sep 2024 12:45
Nightingale Health
Nightingale Health’s Board of Directors resolved on amendment to CEO’s incentive program20 sep 2024 08:00
Nightingale Health
Nightingale Health Plc Financial Statements Release 1 July 2023 – 30 June 202419 sep 2024 12:00
Nightingale Health
Nightingale Health receives third regulatory approval for healthcare use from Health Sciences Authority in Singapore05 sep 2024 13:30
Nightingale Health
Nightingale Health to publish Financial Statements Release for financial year July 2023 – June 2024 on 20 September 202420 aug 2024 08:45
Nightingale Health
Nightingale Health attains UKCA marking for its blood analysis technology to bring its technology to healthcare use in the United Kingdom20 aug 2024 08:15
Nightingale Health
Nightingale Health receives additional regulatory approval for healthcare use from Health Sciences Authority in Singapore06 aug 2024 17:00
Nightingale Health
Nightingale Health and U.S.-based Phenome Health announce a partnership to strive towards the most transformational change in the history of healthcare04 jul 2024 13:35
Nightingale Health
Nightingale Health Plc – Managers’ transactions – Olli Karhi03 jul 2024 15:35
Nightingale Health
Summary of Financial Year 7/2023 - 6/2024: Nightingale Health achieved several breakthroughs in adopting the company’s technology in healthcare28 jun 2024 13:00
Nightingale Health
Inside Information: 23andMe and Nightingale Health Announce Strategic Collaboration to Pilot Blood Biomarker Panel28 jun 2024 08:35
Nightingale Health
Inside information: Nightingale Health and Boston Heart Diagnostics enter strategic partnership to sell Nightingale’s Health Check in the United States27 jun 2024 15:15
Nightingale Health
Nightingale Health and ZOE expand research collaboration to include self-collected blood samples27 jun 2024 13:45
Nightingale Health
Nightingale Health acquires all intellectual property assets of the Velvet™ blood collection device and secures its position as the sole provider of a fully integrated remote health check solution18 jun 2024 16:25
Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Cor Group Oy)18 jun 2024 16:15
Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Pasi Soininen)18 jun 2024 16:05
Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Teemu Suna)18 jun 2024 14:20
Nightingale Health
Disclosure under Chapter 9, Section 10 of the Securities Markets Act (Antti Kangas)11 jun 2024 13:50
Nightingale Health
Conversion of Nightingale Health Plc’s Series A shares to Series B shares06 jun 2024 08:30
Nightingale Health
Health check based on advanced blood analysis technology builds a better foundation for public health23 maj 2024 09:45
Nightingale Health
Nightingale Health’s Board of Directors extended the subscription period of employee option rights21 maj 2024 10:15
Nightingale Health
Nightingale Health launches new website aligned with the B2B and B2G strategy25 apr 2024 10:50
Nightingale Health
Inside information: Nightingale Health achieves one of its business targets for this financial year by winning contracts in medical research with a total contract value of at least EUR 3.2 million16 apr 2024 07:45
Nightingale Health
Nightingale Health to establish a laboratory in the United States with Weill Cornell Medicine as the first customer12 apr 2024 11:45
Nightingale Health
Supplement to the release: Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.12 apr 2024 06:15
Nightingale Health
Inside Information: Nightingale Health enters into agreement to analyze 50,000 blood samples with Kaiser Foundation Health Plan, Inc.29 mar 2024 08:00
Nightingale Health
Nightingale Health has completed the acquisition of Welltus Inc21 mar 2024 05:50
Nightingale Health
Correction: Conversion of Nightingale Health Plc’s EMP shares to Series B shares20 mar 2024 16:00
Nightingale Health
Conversion of Nightingale Health Plc’s EMP shares to Series B shares19 mar 2024 07:00
Nightingale Health
Nightingale Health’s technology used to analyze Uganda’s General Population Cohort (GPC)07 mar 2024 14:30
Nightingale Health
Supplement to the release: Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc07 mar 2024 08:00
Nightingale Health
Inside information: Nightingale Health strengthens its Japan business by acquiring Welltus Inc07 mar 2024 07:00
Nightingale Health
Nightingale Health’s Half-year report: Healthcare implementations progressing in Finland and Singapore28 feb 2024 13:15
Nightingale Health
Nightingale Health to publish half-year report for July – December 2023 on 7 March 202423 feb 2024 08:00
Nightingale Health
Nightingale Health receives regulatory approval for healthcare use from Health Sciences Authority in Singapore31 jan 2024 07:00
Nightingale Health
Nightingale Health receives five new patents for its proprietary health risk detection capability19 jan 2024 09:00
Nightingale Health
Nightingale Health joins Radical Health Festival Helsinki as Founding Partner to promote urgent global need for preventative health02 jan 2024 08:45
Nightingale Health
Terveystalo begins using Nightingale Health’s blood analysis technology in regular health checks in occupational health13 dec 2023 07:30
Nightingale Health
Nightingale Health completes the analysis of all 500,000 UK Biobank samples creating the world's largest blood biomarker database for chronic disease research and prevention27 nov 2023 17:00
Nightingale Health
Change in Nightingale Health Plc’s Management Team16 nov 2023 16:30
Nightingale Health
Resolutions of the Annual General Meeting and the Board of Directors’ organizational meeting of Nightingale Health Plc15 nov 2023 08:15
Nightingale Health
Inside information: Nightingale Health and Innoquest Diagnostics enter into collaboration agreement to make Nightingale Health’s technology accessible in the Southeast Asia region01 nov 2023 09:45
Nightingale Health
Research study abstract by Nightingale Health on heart disease prevention wins American Heart Association’s Paul Dudley White International Scholar Award19 okt 2023 14:00
Nightingale Health
Notice to the Annual General Meeting of Nightingale Health Plc19 okt 2023 08:00
Nightingale Health
Nightingale Health’s Annual Report for financial year 2022–2023 has been published17 okt 2023 09:15
Nightingale Health
Nightingale Health Plc – Managers’ transactions – Ilkka Laurila16 okt 2023 14:00
Nightingale Health
Nightingale Health’s Board of Directors resolved on new share-based incentive programs and amendments to existing incentive programs02 okt 2023 08:30
Nightingale Health
Nightingale Health Plc – Managers’ transactions – Tuukka Paavola28 sep 2023 08:00
Nightingale Health
Nightingale Health Plc Financial Statements Release 1 July 2022 – 30 June 202326 sep 2023 08:00
Nightingale Health
Nightingale Health receives three new patents further strengthening its IP portfolio